ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,280Medicare Part D Prescriptions Filled, Including Refills

Rank: 59 out of 1006

$912K Total Retail Price of All Prescriptions

Rank: 55 out of 1006

622 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
50% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 622 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

6% of this provider’s 622 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

3% of this provider’s 9,917 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$74 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
LEVOTHYROXINE SODIUM 423 375 1 2
SIMVASTATIN 421 354 2 1
AMLODIPINE BESYLATE 417 378 3 4
METOPROLOL SUCCINATE 366 330 4 12
FUROSEMIDE 345 302 5 6
METOPROLOL TARTRATE 328 288 6 7
LISINOPRIL 310 276 7 3
OMEPRAZOLE 275 208 8 9
WARFARIN SODIUM 268 234 9 8
HYDROCHLOROTHIAZIDE 247 217 10 11
METFORMIN HCL 226 173 11 10
ATORVASTATIN CALCIUM 213 181 12 5
GLYBURIDE 180 158 R 13 65
NEXIUM 161 108 14 28
POTASSIUM CHLORIDE 151 136 15 30
DIGOXIN 133 109 16 52
DONEPEZIL HCL 131 131 17 17
ZOLPIDEM TARTRATE 130 108 18 14
ADVAIR DISKUS 127 109 19 37
SERTRALINE HCL 123 95 20 19
TRAMADOL HCL 118 87 21 35
CRESTOR 113 59 22 18
GABAPENTIN 109 95 23 20
CYMBALTA 107 78 24 41
PREDNISONE 106 89 25 33
TAMSULOSIN HCL 104 85 26 23
ZETIA 103 89 27 51
ESCITALOPRAM OXALATE 103 75 27 27
LOVASTATIN 100 75 29 44
ATENOLOL 99 89 30 13
CLOPIDOGREL 99 85 30 46
LOSARTAN POTASSIUM 98 91 32 22
ALENDRONATE SODIUM 97 74 33 29
OXYCODONE-ACETAMINOPHEN 93 59 S2 34 57
AMITRIPTYLINE HCL 91 81 R 35 150
CYCLOBENZAPRINE HCL 91 45 R 35 113
TRIAMTERENE-HCTZ 90 87 37 58
PRAVASTATIN SODIUM 86 84 38 15
OXYCODONE HCL 86 59 S2 38 54
DOXAZOSIN MESYLATE 84 76 40 87
HYDROCODONE-ACETAMINOPHEN 84 61 S3 40 25
PAROXETINE HCL 81 69 42 62
CITALOPRAM HBR 80 77 43 24
ENALAPRIL MALEATE 80 67 43 83
OXYCONTIN 79 13 S2 45 98
JANUVIA 74 72 46 49
TRAZODONE HCL 69 54 47 21
PLAVIX 65 56 48 61
DOXYCYCLINE HYCLATE 62 50 49 130
DIOVAN 61 41 50 16
IPRATROPIUM-ALBUTEROL 60 60 51 73
CELEBREX 57 49 52 90
CARVEDILOL 57 32 52 36
LANTUS 55 55 54 43
LANSOPRAZOLE 54 37 55 141
FLUTICASONE PROPIONATE 54 39 55 55
SINGULAIR 54 34 55 82
SPIRONOLACTONE 53 30 58 71
LYRICA 52 34 59 115
LIPITOR 52 46 59 47
DEXILANT 52 37 59 142
NAMENDA 51 51 62 34
VESICARE 51 35 62 163
SYNTHROID 51 45 62 42
PEN NEEDLE 50 35 65 128
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 3, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.